<DOC>
	<DOCNO>NCT02443805</DOCNO>
	<brief_summary>The objective study assess efficacy safety 12 month treatment 300 IR STG320 sublingual tablet compare placebo adult adolescents HDM-associated allergic rhinitis .</brief_summary>
	<brief_title>Efficacy Safety STG320 Sublingual Tablets House Dust Mite ( HDM ) Allergen Extracts Adults Adolescents With HDM-associated Allergic Rhinitis</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis , Allergic , Perennial</mesh_term>
	<criteria>Main Patients HDMassociated allergic rhinitis ( AR ) least 1 year Patients sensitize D. pteronyssinus ( D. pte ) and/or D. farinae ( D. far ) define skin prick test HDMspecific serum IgE Main A history rhinitis , rhinoconjunctivitis asthma allergens HDM , likely result rhinitis symptom evaluation period Partly control uncontrolled asthma Controlled asthma require controller treatment ( ) consistent GINA 2014 treatment Steps 3 5</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>